A researcher in a lab looking at a tablet.

Category: ALK Experts

  • Angel Qin portrait.
    ,

    An Interview with Dr. Angel Qin: “From Leukemia to ALK+ NSCLC: Finding a New Way to Overcome Drug Resistance”

    Editors Note: This interview is by Juhi Kunde, Director of Patient Gateways and Science Marketing at LUNGevity and was orginally posted on their web site on March 5, 2024. Dr. Angel Qin, MD, medical oncologist at the University of Michigan and one of the recipients of our ALK Positive Lung Cancer Research Awards. ALK Positive,…

    Read More

  • Dr. Alice Shaw
    ,

    An Interview with Dr. Alice Shaw at ALKtALK, Feb. 2022

    Dr. Alice Shaw, MD, PhD, Boston, MA Global Head of Translational Clinical Oncology at Novartis Attending physician, Center for Thoracic Cancers at Massachussets General Hospital Associate Professor of medicine at […]

    Read More

  • ,

    Dr. Ou at ALKtALK

    Dr. Ignatius Sai-Hong Ou – Professor in Hematology-Oncology, Medical Oncology University of California, Irvine Editor-in-Chief of Lung Cancer: Targets and Therapy Associate Editor of Journal of Thoracic Oncology Question: We […]

    Read More

  • ,

    Dr. Vincent Lam at ALKtALK

    Director, Esophageal Cancer Research Program, Assistant Professor of Oncology Expertise: Esophageal Cancer & Lung cancer  Dr Lam: I am so excited to join your conversation tonight on a Sunday evening.  […]

    Read More

  • ,

    Dr. Benjamin Levy & NPC Rasheda Persinger join ALKtALK

    BENJAMIN PHILLIP LEVY, MD, Clinical Director of Medical Oncology Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital Associate Professor of Oncology RASHEDA PERSINGER, Nurse Practitioner Johns Hopkins Sidney […]

    Read More

  • ,

    Dr. Justin Gainor & Dr. Aaron Hata join ALKtALK

    Dr. Justin Gainor, MD Director of Center for Thoracic Cancers & Director of Targeted Immunotherapy at Massachusetts General Hospital, Boston Assistant Professor of Medicine at Harvard Medical School “It’s great […]

    Read More

  • ,

    Dr. Mark Awad & Dr. Roberto Chiarle join ALKtALK

    Mark Awad, MD, PhD  Clinical Director, Thoracic Oncology Treatment Center Assistant Professor of Medicine, Harvard Medical School I hope everyone is safe, warm, and healthy tonight. I am the Clinical […]

    Read More

  • ,

    Dr. Jessica Lin and Dr. Ibiayi Dagogo-Jack join ALKtALK

    Dr. Jessica Lin Attending physician, Hematology/Oncology, Massachusetts General Hospital Instructor, Medicine, Harvard Medical School Dr. Lin: I first began interested in oncology in my undergraduate years. I started out as […]

    Read More

  • ,

    Dr. Christine Lovly joins ALKtALK

    Editor’s Note: A special thanks to Marc Rosenzweig for creating and scheduling the ALKtALK programs. Alice Chou graciously committed her time to transcribe thisALKtALK with Dr. Lovly so that it […]

    Read More

  • Dr. Ross Camidge joins ALKtALK

    Editor’s Note: A special thanks to Marc Rosenzweig for creating and scheduling the ALKtALK programs. Alice Chou graciously committed her time to transcribe the January ALKtALK with Dr. Camidge so […]

    Read More

  • Dr. Alice Shaw joins ALKtALK

    Editor’s Note: A special thanks to Marc Rosenzweig for creating and scheduling the ALKtALK programs. Alice Chou graciously committed her time to transcribe the January ALKtALK with Dr. Shaw so […]

    Read More

  • ALK-positive lung cancer and Covid-19 Update

    Written 7.1.20 We’ve been living with COVID-19 for six months now and we know so much more, not only about this virus, but how it affects people living with lung […]

    Read More